Testing the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The Treatment of Advanced Solid Tumors Expressing the HER2 Protein or Gene, The DASH Trial
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Ensem Therapeutics
Seagen Inc.
PMV Pharmaceuticals, Inc
Mayo Clinic
Kivu Bioscience Inc.
STORM Therapeutics LTD
Eli Lilly and Company
Terremoto Biosciences Inc.
Jazz Pharmaceuticals
Kaiser Permanente
AstraZeneca
Seagen Inc.
Duke University
Radiopharm Theranostics, Ltd
Arvinas Inc.
Tizona Therapeutics, Inc